WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

COMPARISION OF EFFECT OF NEBULIZATION WITH DIFFERENT COMBINATIONS OF MEDICATIONS IN PEDIATRIC PATIENTS WITH WALRI

K. Blessy lavanya*, T.Lakshmi vasundhara, Syed Zahed pasha, Mr.G.Veeramani, Dr. S. Chidambaranathan

ABSTRACT

AIM: To investigate which of the combination of nebulisation is better when compared to each other in management of WALRI in pediatric patients. METHODOLOGY: This study is conducted for a period of 6months (November 2012 to April 2013) in RMMCH a 1600 bedded tertiary care multispecialty hospital situated in southern India. A total of 65 patients in age group of new born to 12 years are enrolled of these 16 (GROUP A) received Ipratropiumbromide+ Salbutamol+ Budesonide, 13 (GROUP B) received Levosalbutamol sulphate+ Budesonide, 13 (GROUP C) received Ipratropiumbromide+ Salbutamol + Ambroxlo+ Hypertonic solution, 23 (GROUP D) received Ipratropiumbromide+Salbutamol+Budesonide+Ambroxol . The respiratory rate, heart rate, overall clinical conditions(using YALES observation scale), RDAI score were measured before 30 minutes and after 20 minutes of nebulization. Results: Both Group A and Group C shows significant improvement in overall RDAI score whereas Gropu A (Ipratropiumbromide+Salbutamol+Budesonide) shows better improvement in heart rate, respiratory rate, and other clinical conditions. Conclusion: Ipratropiumbromide+Salbutamol+Budesonide is the most effective combination for the treatment of WALRI in pediatric patients.

Keywords: WALRI (wheeze associated lower respiratory tract infection), Nebulization, pediatrics


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More